Gene: NDUFB6
Official Full Name: NADH:ubiquinone oxidoreductase subunit B6provided by HGNC
Gene Summary: The protein encoded by this gene is a subunit of the multisubunit NADH:ubiquinone oxidoreductase (complex I). Mammalian complex I is composed of 45 different subunits. It locates at the mitochondrial inner membrane. This protein has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. Alternative splicing occurs at this locus and three transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Jan 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36436 | NDUFB6 Knockout cell line (HeLa) | Human | NDUFB6 | 1:3~1:6 | Negative | Online Inquiry |
KO36437 | NDUFB6 Knockout cell line (HCT 116) | Human | NDUFB6 | 1:2~1:4 | Negative | Online Inquiry |
KO36438 | NDUFB6 Knockout cell line (HEK293) | Human | NDUFB6 | 1:3~1:6 | Negative | Online Inquiry |
NDUFB6 Gene Knockout Cell Lines represent a valuable tool in cellular and molecular biology, specifically designed for the study of mitochondrial function and energy metabolism. These cell lines feature a targeted disruption of the NDUFB6 gene, which encodes a crucial subunit of the mitochondrial NADH:ubiquinone oxidoreductase complex (Complex I). By knocking out NDUFB6, researchers can investigate the downstream effects on mitochondrial respiration and explore the pathophysiological mechanisms underlying various mitochondrial diseases.
The primary function of these cell lines lies in their capacity to model disruptions in mitochondrial bioenergetics. By examining Changes in ATP production, reactive oxygen species (ROS) generation, and cellular signaling pathways, scientists can elucidate the role of the NDUFB6 protein in both normal physiology and disease states. These cell lines can also be employed in high-throughput screening assays to test potential pharmacological agents aimed at mitigating mitochondrial dysfunction.
In terms of scientific significance, NDUFB6 Gene Knockout Cell Lines provide essential insights into conditions that stem from mitochondrial impairments, such as neurodegenerative diseases, muscular dystrophies, and cardiomyopathies. This makes them invaluable in both basic research and the development of new therapeutic strategies. Compared to alternatives, these knockout lines offer a highly specific model that mitigates the variability seen in whole-animal studies, allowing for detailed mechanistic insights with reduced confounding factors.
For researchers and clinicians focused on mitochondrial research, the NDUFB6 Gene Knockout Cell Lines stand out due to their precision and the direct impact they can have on advancing our understanding of complex diseases. They empower scientists to generate reproducible results, fostering innovation and discovery in an area of biology where accurate models are critical.
Our company prides itself on the development of high-quality biological products designed to support cutting-edge research. We are committed to providing researchers with reliable tools that enhance their scientific endeavors and contribute to advancements in biomedical science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.